Gerresheimer to Showcase its Silicone Oil-Free Syringe Systems at CPHI Worldwide 2024
The new syringe systems underline Gerresheimer’s expertise as a system and solution provider for highly sensitive innovative drugs.
Global Pharma | 03/09/2024 | By Aishwarya | 832
India Witnesses Increase in Sales of Unapproved Psychotropic FDCs, Reveals Study
The study, titled 'Sales and Regulatory Status of Fixed Dose Combination Psychotropic Drugs in India: A Retrospective Longitudinal Study,' was published in the Journal of Pharmaceutical Policy and Practice.
Global Pharma | 02/09/2024 | By Aishwarya | 485
Akums Drugs Appoints Amrut Medhekar as New CDMO CEO
Akums Drugs and Pharmaceuticals Ltd. has announced the appointment of Amrut Medhekar as Chief Executive Officer of its CDMO business, approved by the company’s Board of Directors in a recent meeting.
Global Pharma | 02/09/2024 | By Aishwarya | 810
Sanyou Bio Rolls Out Comprehensive Monkeypox Product Line
Developed using Sanyou Bio's proprietary 'over-trillion innovative antibody discovery' platform, the monoclonal antibodies span multiple species, including fully human, nano, and mouse antibodies.
Global Pharma | 31/08/2024 | By Aishwarya | 564
Lupin Unveils Doxorubicin Hydrochloride Liposome Injection in US
Lupin has introduced Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials in the United States.
Global Pharma | 31/08/2024 | By Aishwarya | 787
Flagship Pioneering and Quotient Therapeutics Signs Deal with Pfizer
Pioneering Medicines, Flagship’s in-house drug discovery and development unit, is responsible for leading the strategic partnership with Pfizer, including driving the exploration process to rapidly surface potential drug development programs built on Flagship’s diverse bioplatforms and modalities.
Global Pharma | 29/08/2024 | By Aishwarya | 343
Insud Pharma Completes Acquisition of Agile Therapeutics
Insud Pharma operates throughout the value chain of the pharmaceutical industry, offering specialized knowledge in scientific research, development, manufacturing, sale and marketing of a wide range of active pharmaceutical ingredients (APIs).
Global Pharma | 28/08/2024 | By Aishwarya | 1089
Indica Labs and Paige to Expand Integrated AI for Anatomic Pathology Labs
Indica Labs has signed a non-exclusive partnership with Paige, aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP.
Global Pharma | 28/08/2024 | By Aishwarya | 679
Zuellig Pharma Signs Exclusive Distribution Deal with Regeneron to Launch Libtayo
Regeneron is a biotechnology company that invents, develops and commercialises life-transforming medicines for people with serious diseases.
Global Pharma | 28/08/2024 | By Aishwarya | 540
VION Biosciences Acquires Echelon Biosciences
This acquisition serves as the second investment under VION Biosciences, Iron Path Capital’s roll-up platform in the life science sector led by life science industry veteran, Mark Thornton.
Global Pharma | 27/08/2024 | By Aishwarya | 789
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy